Atlas Trials

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

Clinical trial NCT00612742 · COMPLETED

Trial details

NCT number
NCT00612742
Sponsor
BioSante Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoactive Sexual Desire Disorder
Start date
2008-01-01
Primary completion
2012-10-01
Enrollment
3656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.